VAXART, INC.

Profile

Company Names

VAXART, INC.

Addresses

20 CALIFORNIA STREET, 7TH FLOOR, SAN FRANCISCO, CA 94111

600 TOWNSEND ST., SUITE 120E, SAN FRANCISCO, CA 94103

Phone Numbers

415-437-0132

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$36,868,416.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2013-07-24 
$19,999,997.00 
$20,000,000.00 
$3.00 
Equity 
1
2009-12-15 
$16,868,419.00 
$16,868,425.00 
$6.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
CORNWELL 
EXECUTIVE OFFICER
VAXART, INC.   |  NORTHPASS, INC.
MICHAEL 
 
FINNEY 
DIRECTOR, EXECUTIVE OFFICER
WAVEMARK INC   |  PHARMASECURE, INC.   |  INNERSCOPE RESEARCH, INC.   |  VAXART, INC.   |  MISSION MOTOR CO.   |  THRIVE BIOSCIENCE, INC.   |  SEQWELL INC.   |  S2 GENOMICS, INC.
WOUTER 
 
LATOUR 
EXECUTIVE OFFICER, DIRECTOR
VAXART, INC.
JAN 
 
LESCHLY 
DIRECTOR
ELEVATION PHARMACEUTICALS INC   |  VAXART, INC.
DAVID 
 
LIEBOWITZ 
EXECUTIVE OFFICER
VIVALDI BIOSCIENCES INC   |  VAXART, INC.   |  AROYA INVESTMENT PARTNERS, LP
DAVID 
 
MADDEN 
EXECUTIVE OFFICER
DICERNA PHARMACEUTICALS INC   |  VAXART, INC.   |  NAVITOR PHARMACEUTICALS, INC.   |  HONOR CREMATIONS INC.
RICHARD 
 
MARKHAM 
DIRECTOR
COLUCID PHARMACEUTICALS, INC.   |  VAXART, INC.   |  ANACOR PHARMACEUTICALS INC   |  NEPHROGENEX, INC.
SEAN 
 
TUCKER 
EXECUTIVE OFFICER, DIRECTOR
VAXART, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-08-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-24 
2012-06-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-15 
2010-01-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#